PRME
Prime Medicine, Inc. Common Stock
NASDAQ: PRME · HEALTHCARE · BIOTECHNOLOGY
$3.08
+3.36% today
Updated 2026-08-05
Market cap
$547.27M
P/E ratio
—
P/S ratio
135.66x
EPS (TTM)
$-1.21
Dividend yield
—
52W range
$3 – $7
Volume
3.5M
Prime Medicine, Inc. Common Stock (PRME) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.08
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$2.45
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -2.32% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.